Safety and Efficacy of Modified Folfirinox Versus Gemcis in Bile Duct Tumours

NCT02591030 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

191

Enrollment

OTHER

Sponsor class

Conditions

Bile Duct Cancer

Interventions

DRUG: GEMCIS
DRUG: mFolfirinox

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Collaborators

[object Object]